ORIC Pharmaceuticals Logo

ORIC Pharmaceuticals

🇺🇸
ORIC
US68622P1093

ORIC Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative cancer therapies. The firm focuses on overcoming treatment resistance through precision oncology medicines, aiming to significantly improve therapeutic outcomes for patients battling various cancers.

Next Quarterly Earnings

Monday, November 9, 2026
CW 46
After-Hours
In 74 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 12, 2026

Stock Price

Frequently asked questions

When will ORIC Pharmaceuticals report its next quarterly earnings?

ORIC Pharmaceuticals is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did ORIC Pharmaceuticals last report quarterly earnings?

ORIC Pharmaceuticals last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -0.38 USD.

How often has ORIC Pharmaceuticals beaten expectations?

ORIC Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the ORIC Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.38
Actual:
Q2 2026
Missed
Estimate:-$0.36
Actual:-$0.38
Difference:-$0.02
Price reaction (1 day):+27.1 %
Price reaction (7 days):+28.5 %
Q1 2026
Missed
Estimate:-$0.32
Actual:-$0.34
Difference:-$0.02
Price reaction (1 day):-0.6 %
Price reaction (7 days):-6.7 %
Q3 2025
Beat
Estimate:-$0.37
Actual:-$0.30
Difference:+$0.07
Q2 2025
Beat
Estimate:-$0.40
Actual:-$0.33
Difference:+$0.07
Q1 2025
Missed
Estimate:-$0.44
Actual:-$0.47
Difference:-$0.03

Earnings statistics

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-2.2%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
ORIC Pharmaceuticals
Ticker Symbol
ORIC
ISIN
US68622P1093
Country
🇺🇸
USA
Sector